Episode Details

Why is a Schedule I drug like medical cannabis easier to get than a Schedule II drug like Vyvanse or Adderall? This episode unpacks the strange asymmetry in U.S. drug policy — where the more "illegal" substance has smoother patient access than medications the government acknowledges have medical value. We trace the root cause to DEA production quotas that stayed flat during a pandemic-era surge in ADHD diagnoses, corporate over-compliance by pharmacy chains like CVS and Walgreens, and a thirty-year cannabis advocacy strategy that routed around federal law entirely. For ADHD patients stuck driving to fifteen pharmacies or counting out old capsules at the counter, we also explore what advocacy could look like — and why the cultural stigma around stimulants has made their regulatory cage only tighter. Episode #156420 — open it directly at myweirdprompts.com/156420